Ibrance approval expanded to include men with breast cancer
(HealthDay)—U.S. Food and Drug Administration approval of Ibrance (palbociclib) capsules has been widened to include men with hormone receptor-positive, human […]
» Read moreHome »
nohealthproblemsnews.com
Home »
(HealthDay)—U.S. Food and Drug Administration approval of Ibrance (palbociclib) capsules has been widened to include men with hormone receptor-positive, human […]
Ibrance approval expanded to include men with breast cancer